Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay

Clin Pharmacol Ther. 2009 Sep;86(3):285-9. doi: 10.1038/clpt.2009.61. Epub 2009 Apr 29.

Abstract

The impact of pretransplant T-cell sensitivity testing using carboxylfluorescein diacetate succinimidyl ester (CFSE)-based flow cytometry was studied in 32 patients with chronic renal failure. There was considerable interindividual variation in the inhibitory effects of cyclosporine (CSA), tacrolimus (TAC), and prednisolone (PRD) but only a small amount of interindividual variation for mycophenolic acid (MPA). Patients with high sensitivity to CSA tended to experience viral reactivation. In addition to post-transplant blood-level monitoring, pretransplant pharmacodynamics could provide useful information on optimal and safe immunosuppressive therapy.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cell Proliferation / drug effects
  • Cyclosporine / pharmacokinetics
  • Cyclosporine / pharmacology
  • Female
  • Fluoresceins*
  • Fluorescent Dyes
  • Humans
  • Immunosuppressive Agents / pharmacokinetics*
  • Immunosuppressive Agents / pharmacology*
  • Kidney Failure, Chronic / surgery
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Prednisolone / pharmacokinetics
  • Prednisolone / pharmacology
  • Prospective Studies
  • Succinimides*
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • Tacrolimus / pharmacokinetics
  • Tacrolimus / pharmacology

Substances

  • 5-(6)-carboxyfluorescein diacetate succinimidyl ester
  • Fluoresceins
  • Fluorescent Dyes
  • Immunosuppressive Agents
  • Succinimides
  • Cyclosporine
  • Prednisolone
  • Tacrolimus